Experienced pharmaceutical leader with over 17 years of industry expertise across multiple therapeutic areas. Currently serving as Global Head of Diseases of Aging and Regenerative Medicine (DARe), leading strategic and scientific direction for teams across the US and Switzerland.

- Deep expertise in end-to-end drug discovery, from target identification to human proof-of-concept

- Proven track record delivering two first-in-class clinical candidates (Phase 2a)

- Strong leader of high-performing, multidisciplinary teams, fostering collaboration and scientific innovation

- Effective communicator, aligning senior stakeholders and cross-functional teams on strategy and execution